529 filings
Page 7 of 27
4
Holuka Eugene Myron
26 Jul 21
Citius Pharmaceuticals / Eugene Myron Holuka ownership change
5:01pm
4
Webb Carol
26 Jul 21
Citius Pharmaceuticals / Carol Webb ownership change
5:00pm
424B4
CTXR
Citius Pharmaceuticals Inc
23 Jul 21
Prospectus supplement with pricing info
4:30pm
EFFECT
CTXR
Citius Pharmaceuticals Inc
9 Jul 21
Notice of effectiveness
12:15am
8-K
CTXR
Citius Pharmaceuticals Inc
7 Jul 21
Regulation FD Disclosure
9:25am
POS AM
CTXR
Citius Pharmaceuticals Inc
2 Jul 21
Prospectus update (post-effective amendment)
4:15pm
8-K
CTXR
Citius Pharmaceuticals Inc
1 Jul 21
Other Events
9:25am
S-8
CTXR
Citius Pharmaceuticals Inc
22 Jun 21
Registration of securities for employees
4:39pm
8-K/A
CTXR
Citius Pharmaceuticals Inc
22 Jun 21
Material Modifications to Rights of Security Holders
4:31pm
8-K
CTXR
Citius Pharmaceuticals Inc
8 Jun 21
Citius Pharmaceuticals Achieves Next Interim Analysis Milestone in its Mino-LokĀ® Phase 3 Trial
9:15am
8-K
CTXR
Citius Pharmaceuticals Inc
7 Jun 21
Citius Pharmaceuticals to be Added to Russell
9:15am
DEFA14A
CTXR
Citius Pharmaceuticals Inc
28 May 21
Additional proxy soliciting materials
4:33pm
8-K
CTXR
Citius Pharmaceuticals Inc
24 May 21
Submission of Matters to a Vote of Security Holders
9:25am
EFFECT
CTXR
Citius Pharmaceuticals Inc
21 May 21
Notice of effectiveness
12:15am
424B3
CTXR
Citius Pharmaceuticals Inc
20 May 21
Prospectus supplement
4:15pm
CORRESP
CTXR
Citius Pharmaceuticals Inc
19 May 21
Correspondence with SEC
12:00am
UPLOAD
CTXR
Citius Pharmaceuticals Inc
18 May 21
Letter from SEC
12:00am
S-3
CTXR
Citius Pharmaceuticals Inc
Shelf registration
13 May 21
8:30am
10-Q
2021 Q2
CTXR
Citius Pharmaceuticals Inc
Quarterly report
13 May 21
8:15am
8-K
CTXR
Citius Pharmaceuticals Inc
13 May 21
Citius Pharmaceuticals, Inc. Reports Second Fiscal Quarter 2021 Financial Results and Provides General Business Update
8:00am